Stage Stores, Inc. (NYSE:SSI) tinted gains of +2.91% (+0.08 points) to US$2.83. The volume of 0.14 Million shares climbed down over an trading activity of 283 Million shares. EPS ratio determined by looking at last 12 month figures is -1.35. Over the same time span, the stock marked US$3.18 as its best level and the lowest price reached was US$1.45. The corporation has a market cap of US$80.12 Million.
Stage Stores, Inc. (NYSE:SSI)’s earnings per share has been growing at a -24.8 percent rate over the past 5 year when average revenue increase was noted as -0.4 percent. The return on equity ratio or ROE stands at -10.7 percent while most common profitability ratio return on investment (ROI) was -5.6 percent. The company’s institutional ownership is monitored at 53.5 percent. The company’s net profit margin has achieved the current level of -2.3 percent and possesses 22.8 percent gross margin.
Ophthotech Corporation (NASDAQ:OPHT) is worth US$102.31 Million and has recently risen 2.91% to US$2.83. The latest exchange of 0.19 Million shares is below its average trading activity of 189.29 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$3.6 while the mean 12-month price target for the shares is US$3.25.
Currently, the stock carries a price to earnings ratio of 0.61, a price to book ratio of 3.63, and a price to sales ratio of 0.49. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown 18.3%. With an institutional ownership near 63.3%, it carries an earnings per share ratio of 4.67.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 3 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 1 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 3.25.